Stanley Xu, PhD, is the Head of Biostatistics and an Investigator at the Institute for Health Research. He is an Adjunct Associate Professor in the Department of Biostatistics and Informatics at the School of Public Health at the University of Colorado. He is responsible for developing analytic strategies for a variety of research problems in health outcomes and health services research and overseeing work of analytic staff. His research areas include longitudinal data analysis, count data analysis, missing data and survival analysis.
1RO1HS021492-01 (Glanz) AHRQ
Randomized Intervention Trial to Evaluate a Vaccine Social Media Website.
The objective of this project is to conduct a randomized intervention trial to test the measure the effectiveness of an interactive, social media website for parents who are concerned about vaccines.
Role: Lead Biostatistician
HHSF2232009100061 (Li) FDA
Two-dimensional scan statistics for assessing vaccine safety in pregnancy.
Efforts to Develop the Sentinel Initiative: Data Holder Common Data Model Infrastructure
The Sentinel System will be a national electronic active surveillance system that greatly enhances the ability of the FDA to track the safety of FDA-regulated drugs, biologics, and medical devices. The pilot program, known as Mini-Sentinel, is the Agency’s first step towards building this nationwide rapid-response electronic safety surveillance system. Role: Co-I
Contract # 200-2012-53582 (Glanz) CDC
Vaccine Safety DatalinkTask Order # 001 Infrastructure
The major goal of this project is to evaluate the safety of currently licensed vaccines in the U.S. To accomplish this goal, we provide electronic clinical data to the weekly dynamic data files and lead specific vaccine safety studies within the VSD.
Role: Co-I/Lead Biostatistician
NIH, KL2 TR000156 (PI: Sokol)
Colorado Clinical and Translational Sciences Institute (CCTSI)
Role: Biostatistician/Steering committee of BIRD core